Arax Advisory Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Arax Advisory Partners's VCYT Position: Q2 2026 in Review
Arax Advisory Partners increased its Veracyte (VCYT) stake by 407% in Q2 2026, buying an estimated $16.9K and bringing the position to 502 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3687.
Arax Advisory Partners first reported a position in VCYT in Q4 2021 and has held it in 17 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Arax Advisory Partners held 502 shares of Veracyte worth $29.5K as of Q2 2026.
- Arax Advisory Partners bought 403 Veracyte shares in Q2 2026, an estimated $16.9K.
- Veracyte made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3687 holding.
- Arax Advisory Partners first reported a position in Veracyte in Q4 2021 and has held it in 17 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.